NeuroTech is a pre-clinical stage biotechnology company pioneering an implant to protect against retinal degeneration using Trans-scleral Electrical Stimulation.
Established in 2011, Neurotech is the first biotechnology company in Hong Kong to pursue commercialization of a Class III active medical implant.
Current R&D center is located in Hong Kong Science Park.
地址: 47/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay, Hong Kong
電話: (852) 9790 4653